Riskpilot← Back to searchSign inGet full accessRAFTEN AS
ASActiveOrg 864124062Romsveien 325B, 3179 ÅsgårdstrandWholesale of pharmaceutical and medical goods · NACE 4646Est. 19920 employees
Revenue 2024
NOK 0
EBITDA margin
—
-1356% vs 2023
Equity ratio
-134588.2%
Financial strength
Net profit 2024
NOK -4,4M
-3121% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -3,9M | -1356% |
| Net profit | NOK -4,4M | -3121% |
| Total assets | NOK 3K | -100% |
| Equity | NOK -4,1M | -1355% |
| Employees | 0 | — |
Legal name
RAFTEN AS
Org number
864124062
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
14. mai 1992
Share capital
NOK 320 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Produksjon, kjøp og salg av kalenderprodukter, samt handel med aksjer og verdipapirer, herunder lånefinasierte investeringer med verdipapirer og valuta, hvor selskapet kan pantsette sine aktiviteter i den forbindelse.
Address
Romsveien 325B, 3179 Åsgårdstrand
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −31 | −101 | −690 | −267 | −3 884 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −31 | −101 | −690 | −267 | −3 884 |
| Net financials | −134 | 130 | 548 | 148 | −386 |
| Profit before tax | −165 | 28 | −142 | −118 | −4 270 |
| Tax | −36 | 6 | 100 | 18 | 120 |
| Net profit | −128 | 22 | −241 | −136 | −4 390 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 921 | 4 312 | 4 285 | 4 230 | 3 |
| Equity | 722 | 744 | 460 | 324 | −4 066 |
| Long-term debt | 0 | 0 | 0 | 0 | 3 949 |
| Short-term debt | 3 199 | 3 568 | 3 825 | 3 906 | 120 |
| Total debt | 3 199 | 3 568 | 3 825 | 3 906 | 4 069 |
EBITDA margin
-388417100.0%
This company
15.8%
Market median
-2458336176% vs market
20202024
Equity ratio
-134588.2%
This company
38.2%
Market median
-352425% vs market
20202024
Return on equity
-438987500.0%
This company
18.4%
Market median
-2385801730% vs market
20202024
Net profit margin
-438987500.0%
This company
8.1%
Market median
-5419598865% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
1.00×
This company
0.62×
Market median
-61% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
GE Deputy Member | Deputy Member | 2007 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2007 | |
| Chairman | 2007 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
As Ripley
RAFTEN AS Board members of RAFTEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Gunnhild Eik | Deputy Member | 0 companies |
| Bjørn Olaf Hagen | Board of Directors | 0 companies |
| Øyvind Stabell Hagen | Chairman | 0 companies |